Want to see AU:OAK full AI Analyst Report?
Top Page
Oakridge Internatinal Ltd
(Sydney:OAK)
Select Model
Select Model
Rating:54Neutral
Price Target:
AU$0.08
▼(-6.25% Downside)
Action:Reiterated
Date:09/26/26
The score is primarily supported by improving 2026 fundamentals (return to net profitability and positive operating/free cash flow) and a relatively conservative balance sheet. This is tempered by continued negative core operating profitability, margin pressure and weak cash conversion, plus bearish technical signals (negative MACD, sub-40 RSI, and trading below key longer-term moving averages).
Positive Factors
Accelerating revenue growth
Accelerating revenue indicates stronger commercial traction and an expanding business base. If maintained, the larger revenue platform can improve operating leverage, support reinvestment, and provide a foundation for more durable earnings growth over the next several quarters.
Negative Factors
Negative core operating profit
Negative EBIT and EBITDA show that the core business has not yet established sustainable operating profitability. Positive net income may therefore rely on non-operating items, leaving earnings quality less robust and limiting confidence that revenue growth will consistently translate into operating cash earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating revenue growth
Accelerating revenue indicates stronger commercial traction and an expanding business base. If maintained, the larger revenue platform can improve operating leverage, support reinvestment, and provide a foundation for more durable earnings growth over the next several quarters.
Read all positive factors
Oakridge Internatinal Ltd (OAK) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$2.46M
Dividend YieldN/A
Average Volume (3M)10.38K
Price to Earnings (P/E)18.8
Beta (1Y)0.63
Revenue Growth38.75%
EPS GrowthN/A
CountryAU
Employees1
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)<0.01
Shares Outstanding31,997,850
10 Day Avg. Volume15,100
30 Day Avg. Volume10,378
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)1.43
Price to Sales (P/S)0.63
P/FCF Ratio77.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Oakridge Internatinal Ltd Business Overview & Revenue Model
Company Description
Based in Mile End South, Australia, Oakridge International Limited specializes in creating advanced Internet of Things (IoT) technology solutions. These innovations cater to a broad spectrum of markets, including consumer, commercial, industrial, ...
Oakridge Internatinal Ltd Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
72
Positive
Cash Flow
48
Neutral
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.09M | 2.23M | 814.73K | 1.10M | 496.86K |
| Gross Profit | 630.14K | 1.12M | 481.73K | 89.00K | -253.40K |
| EBITDA | -100.35K | -85.26K | -789.23K | -203.66K | -588.36K |
| Net Income | 109.17K | -128.79K | -761.25K | -116.11K | -531.03K |
Balance Sheet | |||||
| Total Assets | 2.12M | 1.61M | 1.81M | 1.99M | 2.16M |
| Cash, Cash Equivalents and Short-Term Investments | 699.59K | 530.89K | 1.03M | 1.14M | 1.83M |
| Total Debt | 95.45K | 201.94K | 301.05K | 288.77K | 277.32K |
| Total Liabilities | 762.44K | 703.85K | 776.75K | 755.20K | 810.53K |
| Stockholders Equity | 1.36M | 902.25K | 1.03M | 1.23M | 1.35M |
Cash Flow | |||||
| Free Cash Flow | 25.19K | -395.68K | -547.36K | -443.06K | -632.93K |
| Operating Cash Flow | 127.03K | -358.46K | -530.67K | -414.60K | -630.80K |
| Investing Cash Flow | -101.84K | -35.07K | -16.68K | 23.19K | -499.00 |
| Financing Cash Flow | 143.51K | -99.11K | 417.03K | -241.96K | -21.18K |
Oakridge Internatinal Ltd Technical Analysis
Positive
0.08
Price Trends
0.07
Positive
0.07
Positive
0.08
Positive
Market Momentum
<0.01
Negative
81.30
Negative
71.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:OAK, the sentiment is Positive. The current price of 0.08 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.07, and above the 200-day MA of 0.08, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 81.30 is Negative, neither overbought nor oversold. The STOCH value of 71.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:OAK.
Oakridge Internatinal Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
54 Neutral | AU$2.46M | 18.78 | 8.96% | ― | 38.75% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$15.02M | ― | -578.72% | ― | 113.42% | 29.17% | |
49 Neutral | AU$27.17M | -1.59 | -58.13% | ― | 2.08% | -195.31% | |
49 Neutral | AU$11.00M | -11.67 | 11.00% | ― | -20.21% | -66.67% | |
47 Neutral | AU$20.06M | -2.26 | -1688.04% | ― | 11.45% | 0.69% | |
41 Neutral | AU$7.66M | -0.42 | -614.15% | ― | -46.09% | 70.70% |
* Healthcare Sector Average
AU:OAK
Oakridge Internatinal Ltd
0.08
-0.02
-17.20%
AU:BMT
Beamtree Holdings Ltd
0.10
-0.13
-56.52%
AU:AHE
MedAdvisor Limited
0.01
-0.03
-69.05%
AU:CTQ
Careteq Ltd.
0.01
<0.01
16.67%
AU:ICR
InteliCare Holdings Limited
0.02
>-0.01
-25.00%
AU:PCK
PainChek Ltd
0.10
-0.47
-83.16%
Oakridge Internatinal Ltd Corporate Events
Oakridge International Files ASX Corporate Governance Statement and Appendix 4G
Aug 24, 2026
Oakridge International Limited has lodged its annual corporate governance statement for the year ended 30 June 2026 with the ASX, opting to publish the detailed statement on its website in line with Listing Rule 4.10.3. The board has confirmed the...
Oakridge International builds healthcare tech pipeline and upgrades product suite
Jul 31, 2026
Oakridge reported continued operational progress in the June quarter, driven by active project delivery, partner-led sales and ongoing product development across its nurse call and assistive technology portfolio. Customer cash receipts reached $77...
Oakridge Options Lapse, Trimming Potential Share Dilution
Jul 5, 2026
Oakridge International Ltd has updated the market on changes to its capital structure, following the expiry of a tranche of listed options. The company reported that 2,142,914 options, with an exercise price of $0.07 and an expiry date of June 30,...
Oak International Director Boosts Shareholding as Options Expire
Jul 2, 2026
Oak International Limited has reported a change in the indirect interests of director Mr. Con Unerkov, reflecting adjustments in his exposure to the company’s equity through controlled entities. The notice details movements in shareholdings ...
Oakridge International Seeks ASX Quotation for Nearly 5 Million New Shares
Jul 2, 2026
Oakridge International Ltd has applied for quotation on the ASX of 4,999,943 ordinary fully paid shares, with an issue date of June 30, 2026. The application indicates an expansion of the company’s quoted share capital, which may enhance liq...
Oakridge Issues New Shares and Confirms Regulatory Compliance
Jul 2, 2026
Oakridge International Ltd, an ASX-listed company based in Melbourne, operates within Australia’s regulated corporate landscape and is bound by statutory financial reporting and continuous disclosure obligations. Its adherence to these requi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.